Whitebox Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-59,577
Closed -$6.62M 357
2015
Q2
$6.97M Sell
59,577
-39,315
-40% -$4.3M 0.3% 77
2015
Q1
$9.7M Sell
98,892
-9,015
-8% -$915K 0.38% 52
2014
Q4
$10.2M Sell
107,907
-54,485
-34% -$5.64M 0.41% 52
2014
Q3
$17.3M Sell
162,392
-72,355
-31% -$7.08M 0.67% 31
2014
Q2
$19.5M Buy
+234,747
New +$18.3M 0.77% 29
2014
Q1
Sell
-24,150
Closed -$1.81M 424
2013
Q4
$1.81M Buy
24,150
+1,427
+6% +$99.4K 0.08% 189
2013
Q3
$1.43M Buy
22,723
+4,786
+27% +$286K 0.08% 197
2013
Q2
$919K Buy
+17,937
New +$935K 0.05% 211

Other funds holding GILD

Whitebox Advisors's GILD Position: Q3 2015 in Review

Whitebox Advisors sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 59,577 shares — an estimated $6.62M sold.

Whitebox Advisors first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $19.5M in Q2 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Whitebox Advisors reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Whitebox Advisors sold 59,577 Gilead Sciences shares in Q3 2015, an estimated $6.62M.
  • Whitebox Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
  • Whitebox Advisors's Gilead Sciences position peaked at $19.5M in Q2 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Whitebox Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.